Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01143298 | LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects | ||
| NCT01320774 | Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris | ||
| NCT02103725 | A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis | ||
| NCT02549352 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up | ||
| NCT01037881 | LEO 29102 Cream in the Treatment of Atopic Dermatitis | ||
| NCT05117060 | Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis | ||
| NCT01541553 | A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp | ||
| NCT06444867 | A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 | ||
| NCT01707368 | Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation | ||
| NCT04306315 | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight | ||
| NCT05508776 | A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People | ||
| NCT01195831 | Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis | ||
| NCT04949841 | Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials | ||
| NCT01430533 | Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation | ||
| NCT01449513 | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy | ||
| NCT03669757 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis | ||
| NCT02888236 | LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris | ||
| NCT02126371 | LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects | ||
| NCT03442244 | Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects | ||
| NCT01229098 | Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris | ||
| NCT07487948 | Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris | ||
| NCT01768013 | The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris | ||
| NCT01926496 | Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% | ||
| NCT04301362 | Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | ||
| NCT00404196 | LEO19123 Cream in the Treatment of Hand Eczema | ||
| NCT02856542 | Real-life Evaluation of the Daivobet® Gel Applicator | ||
| NCT02379793 | Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects | ||
| NCT01587755 | Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) | ||
| NCT05098821 | Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation | ||
| NCT01922050 | A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis | ||
| NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | ||
| NCT07013201 | A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis | ||
| NCT00392067 | LEO19123 Cream in the Treatment of Atopic Dermatitis | ||
| NCT04305327 | Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis | ||
| NCT02899962 | LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris | ||
| NCT02514694 | LEO 32731 - A Phase I Study in Healthy Subjects | ||
| NCT03476746 | Dermatopharmacokinetic Trial of LEO 90100 Foam | ||
| NCT01963793 | Topical Aprepitant in Prurigo Patients | ||
| NCT03192280 | Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response | ||
| NCT00031096 | Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne | ||
| NCT03526861 | Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). | ||
| NCT01141179 | The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847 | ||
| NCT03569345 | Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate | ||
| NCT04587453 | Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis | ||
| NCT00475605 | A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis | ||
| NCT02636101 | Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study | ||
| NCT00833872 | LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects | ||
| NCT03995550 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese | ||
| NCT05194540 | Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA) | ||
| NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris |
